Characteristics of Long COVID-19 Syndrome

Long COVID Syndrome Clinical Trial

Official title:

Long COVID Syndrom: Charakterisierung Eines Neuen Krankheitsbildes

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04793269
• Other study ID #: 2021-00280
• Status: Active, not recruiting
• Start date: February 23, 2021
• Est. completion date: April 30, 2024

Study information

• Verified date: February 2023
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Characterization of patients with long COVID syndrome including symptoms, medical history and persistent organ damage.

Description:

Some people are very hesitant to recover from a COVID-19 infection and present persistent symptoms. The participants still suffer after the acute phase of the infection from shortness of breath, coughing, chest pain or fatigue. Therefore, a special interdisciplinary consultation was built. The consulatation is not only addressed to people who have been hospitalized due to COVID-19, but also to those with mild symptoms during infection. During the consultation hours, personal health data are collected that serves as the basis for this research project.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 200
• Est. completion date: April 30, 2024
• Est. primary completion date: December 31, 2023
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Long COVID syndrome

• age >= 18 years

• Informed consent

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Long COVID Syndrome
• Syndrome

Intervention

Other:
• No intervention
no intervention

Locations

Country	Name	City	State
Switzerland	University Hospital Zurich	Zurich

Sponsors (1)

Lead Sponsor	Collaborator
Christian Clarenbach

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dyspnea	modified medical research council (scale from 0 to 4). The higher the score the worse the symptoms.	once through study completion, an average of 6 months.
Primary	self-addressed Quality of life	Short form health 36 questionnaire with 8 domains, each rated from 0-100. The higher the score the better subjective quality of life.	once through study completion, an average of 6 months
Primary	Thoracic pain	assessed by medical interview (reported as yes or no)	once through study completion, an average of 6 months
Primary	Medical history	List of relevant morbidities assessed as present/not present by medical interview (e.g. respiratory, cardial, neurological, psychiatric diseases by interview and medical records)	once through study completion, an average of 6 months
Primary	Fibrosis	Assessed by chest CT, rated as present/not present	once through study completion, an average of 6 months
Primary	Myocardial damage	Assessed by myocardial damage, rated as present/not present	once through study completion, an average of 6 months